Safety and tolerability of flexible dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder

類似資料

• Functional improvement and correlations with symptomatic improvement in adults with attention deficit hyperactivity disorder receiving long-acting methylphenidate
  著者:: Buitelaar, J. K., 等
  出版事項: (2012)
• Predictors and impact of non-adherence in adults with attention-deficit/hyperactivity disorder receiving OROS methylphenidate: results from a randomized, placebo-controlled trial
  著者:: Kooij, J J Sandra, 等
  出版事項: (2013)
• Individualizing the dosage of Methylphenidate in children with attention deficit hyperactivity disorder
  著者:: Shirafkan, Hoda, 等
  出版事項: (2020)
• Treating attention-deficit/hyperactivity disorder beyond symptom control alone in children and adolescents: a review of the potential benefits of long-acting stimulants
  著者:: Buitelaar, Jan, 等
  出版事項: (2009)
• The effect of methylphenidate-OROS(®) on the narrative ability of children with attention-deficit hyperactivity disorder
  著者:: Rausch, Tessa L., 等
  出版事項: (2017)